Received Sep 17, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| FLU3 | INFLUENZA (SEASONAL) (FLUZONE) | SANOFI PASTEUR | 1 | UT8792LA | OT |
pregnant women received fluzone vaccine with no reported adverse event; Initial information received on 10-Sep-2025 regarding an unsolicited valid non-serious case received from a Nurse. This case involves a 32 years old pregnant female patient who was exposed to vaccine Influenza Usp Trival A-B Subvirion No Preservative Vaccine [Fluzone] with no reported adverse event. Data regarding this pregnancy were received prospectively, i.e. before pregnancy outcome was known. The reported event occurred at 17 weeks of pregnancy. The date of last menstrual period was reported as 11-May-2025. The estimated due date is 15-Feb-2026. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. The patient had unknown previous pregnancy/ies. On 10-Sep-2025, the pregnant patient received a dose 1 of suspect Influenza Usp Trival A-B Subvirion No Preservative Vaccine Suspension for injection (lot UT8792LA, expiry date- 30-JUN-2025) via intramuscular route in unknown administration site for prophylactic vaccination (Immunisation), with no reported adverse event (exposure during pregnancy) (latency- same day). Reportedly, the patient did not experience any adverse events. Relevant prenatal testing after exposure was not reported. Action taken was not applicable. Additionally, at time of reporting, the pregnancy is still ongoing.